Researchers at the University of Pittsburgh have developed a new antibody-type therapy for SARS-CoV-2, the causative virus for COVID-19. The treatment exploits “nanobodies” – tiny antibody fragments – that are harvested from llama blood. The new nanobody therapy can be used in an inhalable form that may deactivate the virus within the lungs. “Nature is our best inventor,” said Yi Shi, a researcher involved in the study. “The technology we developed surveys SARS-CoV-2 neutralizing nanobodies at an unprecedented scale, which…
